Edition:
India

Chemed Corp (CHE.N)

CHE.N on New York Stock Exchange

266.11USD
11:03pm IST
Change (% chg)

$2.68 (+1.02%)
Prev Close
$263.43
Open
$262.95
Day's High
$266.12
Day's Low
$262.95
Volume
4,635
Avg. Vol
31,169
52-wk High
$266.12
52-wk Low
$163.94

Chart for

About

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians,... (more)

Overall

Beta: 1.12
Market Cap(Mil.): $3,254.67
Shares Outstanding(Mil.): 15.99
Dividend: 0.28
Yield (%): 0.55

Financials

BRIEF-Chemed reaches final agreement to end civil litigation & false claims act brought by U.S. DOJ in May 2013​

* Chemed - Reached final agreement to end civil litigation and false claims act brought by U.S. Department of Justice in May 2013​

31 Oct 2017

Chemed to pay $75 million over false claims lawsuit: Justice Dept

WASHINGTON Chemed Corp and subsidiaries including Vitas Hospice Services LLC and Vitas Healthcare Corp have agreed to pay $75 million to resolve a federal lawsuit alleging false claims for hospice services to Medicare, the U.S. Justice Department said on Monday.

31 Oct 2017

Chemed to pay $75 mln over false claims lawsuit -Justice Dept

WASHINGTON, Oct 30 Chemed Corp and subsidiaries including Vitas Hospice Services LLC and Vitas Healthcare Corp have agreed to pay $75 million to resolve a federal lawsuit alleging false claims for hospice services to Medicare, the U.S. Justice Department said on Monday.

31 Oct 2017

BRIEF-Chemed reports Q3 earnings per share $2.13

* Sees FY 2017 adjusted earnings per share $8.35 to $8.40 excluding items

27 Oct 2017

BRIEF-Chemed Corp increases quarterly dividend 7.7 pct

* Says declared quarterly cash dividend of 28-cents per share Source text for Eikon: Further company coverage:

04 Aug 2017

BRIEF-Chemed Corp qtrly ‍adjusted diluted eps $2.15​

* Chemed Corp qtrly ‍net patient revenue of $285 million, an increase of 2.1%​

26 Jul 2017

Earnings vs. Estimates